An Assessment of Traditional and Genomic Screening in Newborns and their Applicability for Africa

Bailey, 2021, Expert evaluation of strategies to modernize newborn screening in the United States, JAMA Netw Open, 4, 10.1001/jamanetworkopen.2021.40998 Courraud, 2021, Studying autism using untargeted metabolomics in newborn screening samples, J Mol Neurosci : MN, 71, 1378, 10.1007/s12031-020-01787-2 Bick, 2021, An online compendium of treatable genetic disorders, Am J Med Genet Part C, Seminars in medical genetics, 187, 48, 10.1002/ajmg.c.31874 Wang, 2019, Expanded newborn screening for inborn errors of metabolism by tandem mass spectrometry in suzhou, China: disease spectrum, prevalence, genetic characteristics in a Chinese population, 10, 1052 Serinelli, 2018, Undiagnosed congenital heart defects as a cause of sudden, unexpected death in children, J Forensic Sci, 63, 1750, 10.1111/1556-4029.13779 Therrell, 2015, Current status of newborn screening worldwide: 2015, Semin Perinatol, 39, 171, 10.1053/j.semperi.2015.03.002 Hsu, 2018, White paper: pathways to progress in newborn screening for sickle cell disease in sub-saharan Africa, J. trop. dis. publ health, 6, 260 Therrell, 2020, Empowering newborn screening programs in African countries through establishment of an international collaborative effort, J commun gen, 11, 253, 10.1007/s12687-020-00463-7 Esoh, 2021, Sickle cell disease in sub-Saharan Africa: transferable strategies for prevention and care, Lancet Haematol, 8, e744, 10.1016/S2352-3026(21)00191-5 Puck, 2019, Newborn screening for severe combined immunodeficiency and T-cell lymphopenia, Immunol Rev, 287, 241, 10.1111/imr.12729 Schwarze, 2020, The complete costs of genome sequencing: a microcosting study in cancer and rare diseases from a single center in the United Kingdom, Genet Med : official journal of the American College of Medical Genetics, 22, 85, 10.1038/s41436-019-0618-7 Johnston, J., Lantos, J. D., Goldenberg, A., Chen, F., Parens, E., Koenig, B. A., & members of the NSIGHT Ethics and Policy Advisory Board (2018). Sequencing Newborns: A Call for Nuanced Use of Genomic Technologies. Hastings Cent Rep, 48 Suppl 2(Suppl 2), S2–S6. https://doi.org/10.1002/hast.874. Woerner, 2021, The use of whole genome and exome sequencing for newborn screening: challenges and opportunities for population health, Front pediatr, 9, 10.3389/fped.2021.663752 Costich, 2016, The impact of the affordable care act on funding for newborn screening services, Publ health rep (Washington, D.C., 131, 160, 10.1177/003335491613100123 Friedman, 2017, Genomic newborn screening: public health policy considerations and recommendations, BMC Med Genom, 10, 9, 10.1186/s12920-017-0247-4 Cunningham, 2015, Public concerns regarding the storage and secondary uses of residual newborn blood spots: an analysis of print media, legal cases, and public engagement activities, J commun gen, 6, 117, 10.1007/s12687-014-0206-0 Huang, 2022, Application of a next-generation sequencing (NGS) panel in newborn screening efficiently identifies inborn disorders of neonates, Orphanet J Rare Dis, 17, 66, 10.1186/s13023-022-02231-x Wojcik, 2021, Discordant results between conventional newborn screening and genomic sequencing in the BabySeq Project, Genet Med: official journal of the American College of Medical Genetics, 23, 1372, 10.1038/s41436-021-01146-5 Wang, 2021, NeoSeq: a new method of genomic sequencing for newborn screening, Orphanet J Rare Dis, 16, 481, 10.1186/s13023-021-02116-5 Roman, 2020, Genomic sequencing for newborn screening: results of the NC NEXUS project, Am J Hum Genet, 107, 596, 10.1016/j.ajhg.2020.08.001 Adhikari, 2020, The role of exome sequencing in newborn screening for inborn errors of metabolism, Nat Med, 26, 1392, 10.1038/s41591-020-0966-5 Lee, 2021, Resolving misalignment interference for NGS-based clinical diagnostics, Hum Genet, 140, 477, 10.1007/s00439-020-02216-5 Perkin-elmer, 1983, Anal Chem, 55, 157A, 10.1021/ac00253a737 Weismiller, 2017, Expanded newborn screening: information and resources for the family physician, Am Fam Physician, 95, 703 Archer, 2022, Enablers and barriers to newborn screening for sickle cell disease in Africa: results from a qualitative study involving programmes in six countries, BMJ Open, 12, 10.1136/bmjopen-2021-057623 Rota, 2016, Laboratory and clinical evaluation of a feia method for canine serum progesterone assay, Reprod domes anim = Zucht Hygiene, 51, 69, 10.1111/rda.12647 Sanders, 2020, A comparative effectiveness study of newborn screening methods for four lysosomal storage disorders, Int j neonat screen, 6, 44, 10.3390/ijns6020044 Howard, 2015, Whole-genome sequencing in newborn screening? A statement on the continued importance of targeted approaches in newborn screening programmes, Eur J Hum Genet : EJHG (Eur J Hum Genet), 23, 1593, 10.1038/ejhg.2014.289 Hao, 2022, Newborn screening with targeted sequencing: a multicenter investigation and a pilot clinical study in China, J gene genom.Yi chuan xue bao, 49, 13, 10.1016/j.jgg.2021.08.008 Therrell, 2018, Newborn screening in the developing countries, Curr Opin Pediatr, 30, 734, 10.1097/MOP.0000000000000683 Heathfield, 2020, Assessment of candidate variants causative of inborn metabolic diseases in SUDI cases in South Africa, and a case report, Int J Leg Med, 134, 1639, 10.1007/s00414-020-02337-6 Adadey, 2020, Screening for GJB2-r143W-associated hearing impairment: implications for health policy and practice in Ghana, Publ health genom, 23, 184, 10.1159/000512121 Christopher, 2021, Using DNA testing for the precise, definite, and low-cost diagnosis of sickle cell disease and other Haemoglobinopathies: findings from Tanzania, BMC Genom, 22, 902, 10.1186/s12864-021-08220-x DeCristo, 2021, Actionability of commercial laboratory sequencing panels for newborn screening and the importance of transparency for parental decision-making, Genome Med, 13, 50, 10.1186/s13073-021-00867-1 Capalbo, 2019, Optimizing clinical exome design and parallel gene-testing for recessive genetic conditions in preconception carrier screening: translational research genomic data from 14,125 exomes, PLoS Genet, 15, 10.1371/journal.pgen.1008409 Tong, 2022, Application of next generation sequencing in the screening of monogenic diseases in China, 2021: a consensus among Chinese newborn screening experts, World j pediatr : WJP, 18, 235, 10.1007/s12519-022-00522-8 Downie, 2021, Principles of genomic newborn screening programs: a systematic review, JAMA Netw Open, 4, 10.1001/jamanetworkopen.2021.14336 Ali, 2021, Rising pediatric morbidity and mortality in the developing world, Cureus, 13 McCandless, 2020, Mandatory newborn screening in the United States: history, current status, and existential challenges, Birth defects res, 112, 350, 10.1002/bdr2.1653 Polizzi, 2016, Expanded newborn screening: a chess board motif in public health, J Pediatr Biochem Inusa, 2018, Utilising the 'getting to Outcomes®' framework in community engagement for development and implementation of sickle cell disease newborn screening in kaduna state, Nigeria, Int j neonat screen, 4, 33, 10.3390/ijns4040033 Al Riyami, 2012, Detection of inborn errors of metabolism using tandem mass spectrometry among high-risk Omani patients, Oman Med J, 27, 482, 10.5001/omj.2012.115 Johnson, 2016, Metabolomics: beyond biomarkers and towards mechanisms, Nat Rev Mol Cell Biol, 17, 451, 10.1038/nrm.2016.25 Mittal, 2015, Tandem mass spectroscopy in diagnosis and clinical research, Indian J Clin Biochem : Indian J Clin Biochem, 30, 121, 10.1007/s12291-015-0498-9 Stranneheim, 2014, Rapid pulsed whole genome sequencing for comprehensive acute diagnostics of inborn errors of metabolism, BMC Genom, 15, 1090, 10.1186/1471-2164-15-1090 van Campen, 2019, Next generation sequencing in newborn screening in the United Kingdom national health service, Int j neonat screen, 5, 40, 10.3390/ijns5040040 Remec, 2021, Next-Generation sequencing in newborn screening: a review of current state, Front Genet, 12, 10.3389/fgene.2021.662254 Berg, 2017, Newborn sequencing in genomic medicine and public health, Pediatrics, 139, 10.1542/peds.2016-2252 Ross, 2019, Ethical issues in newborn sequencing research: the case study of BabySeq, Pediatrics, 144, 10.1542/peds.2019-1031 Lantos, 2016, Introduction to bioethics special supplement V: ethical issues in genomic testing of children, Pediatrics, 137, S1, 10.1542/peds.2015-3731B Goldenberg, 2012, The ethical hazards and programmatic challenges of genomic newborn screening, JAMA, 307, 461, 10.1001/jama.2012.68 Powell, 2022, Parental guidance suggested: engaging parents as partners in research studies of genomic screening for a pediatric population, Front Genet, 13, 10.3389/fgene.2022.867030 Pereira, 2021, Psychosocial effect of newborn genomic sequencing on families in the BabySeq project: a randomized clinical trial, JAMA Pediatr, 175, 1132, 10.1001/jamapediatrics.2021.2829 Milko, 2018, Evaluating parents' decisions about next-generation sequencing for their child in the NC NEXUS (North Carolina Newborn Exome Sequencing for Universal Screening) study: a randomized controlled trial protocol, Trials, 19, 344, 10.1186/s13063-018-2686-4 Veldman, 2022, Towards next-generation sequencing (NGS)-Based newborn screening: a technical study to prepare for the challenges ahead, Int j neonat screen, 8, 17, 10.3390/ijns8010017 Andrews, 2022, Preparing newborn screening for the future: a collaborative stakeholder engagement exploring challenges and opportunities to modernizing the newborn screening system, BMC Pediatr, 22, 90, 10.1186/s12887-021-03035-x Hinton, C. F., Homer, C. J., Thompson, A. A., Williams, A., Hassell, K. L., Feuchtbaum, L., Berry, S. A., Comeau, A. M., Therrell, B. L., Brower, A., Harris, K. B., Brown, C., Monaco, J., Ostrander, R. J., Zuckerman, A. E., Kaye, C., Dougherty, D., Greene, C., Green, N. S., & Follow-up and Treatment Sub-committee of the Advisory Committee on Heritable Disorders in Newborns and Children (ACHDNC) (2016). A framework for assessing outcomes from newborn screening: on the road to measuring its promise. Mol Genet Metabol, 118(4), 221–229. https://doi.org/10.1016/j.ymgme.2016.05.017. Kong, 2022, Multidisciplinary effort to drive precision-medicine for the future, Front digit health, 4, 10.3389/fdgth.2022.845405 Grosse, 2011, Sickle cell disease in Africa: a neglected cause of early childhood mortality, Am J Prev Med, 41, S398, 10.1016/j.amepre.2011.09.013 Inusa, 2019, Sickle cell disease—genetics, pathophysiology, clinical presentation and treatment, Int J Neonat Screen, 5, 20, 10.3390/ijns5020020 Natalis Wonkam, 2015, Sickle cell disease and H3Africa: enhancing genomic research on cardiovascular diseases in African patients, Cardiovascul j Afr, 26, S50, 10.5830/CVJA-2015-040